Definitive Contract HT942523C0067
Award Date 9/15/23
Potential Completion Date 1/14/26
Potential Value $3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Health Agency (DHA) awarded a $250,000 Small Business Technology Transfer (STTR) Phase I contract to Zymeron Corporation, a minority-owned biotechnology company. The contract is for an "Automated Blood-In, miRNAs-Out Assay to Detect Circulating and Exosome miRNAs" to support DHA's biomedical research and development efforts. This STTR award is focused on early-stage research and development of innovative technologies aligned with the DHA's mission to provide healthcare...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Zymeron Corporation, a minority-owned, for-profit biotechnology company, under the Small Business Innovation Research (SBIR) Program Phase I. The contract, valued at $197,000.00, is for research and development services related to an unspecified biomedical or public health initiative. As a total small business set-aside, this award aligns with Zymeron's...
- This is a $149,967.27 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Zymeron Corporation, a minority-owned small business. The contract supports research and development of innovative biotechnology solutions related to areas such as protein degradation, antibacterials, antivirals, and drug delivery systems. As a prime contractor, Zymeron has a history of providing medical...
- This is a firm fixed-price purchase order awarded to Zymeron Corporation, a minority-owned small business, under the Department of the Army Medical Command's Small Business Innovation Research (SBIR) program. The $250,000.00 Phase I contract is for the research and development of a "Novel Aerosol Therapy for Immediate and Sustained ARDS Management". Zymeron, a biotechnology company focused on areas like drug delivery systems, will perform this medical research at its facilities in...
- The Defense Health Agency (DHA) awarded a Small Business Technology Transfer (STTR) Phase I contract to Zymeron Corporation, a minority-owned biotechnology company, for the "Development of WoundShield for Pseudomonas aeruginosa-caused Wound Infections". This $249,995.45 firm-fixed-price purchase order will support research and development efforts to advance this novel medical solution. As the prime contractor, Zymeron will perform the work at its facility in Research Triangle Park,...
- This is a $167,496.80 STTR Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the minority-owned small business Zymeron Corporation. The contract is for research and development of innovative biotechnology solutions, including technologies related to protein degradation, antibacterials, antivirals, and drug delivery systems. Zymeron has experience providing medical research, engineering services, IT solutions, and biotech...
- This contract was awarded by the Department of the Army Materiel Command TACOM Life Cycle Management Command to Zymeron Corporation, a minority-owned small business. The contract is for Phase I SBIR (Small Business Innovation Research) research, with a firm fixed-price contract type and a potential value of $162,482.83. Zymeron is a biotechnology company that focuses on developing innovative technologies in areas such as protein degradation, antibacterials, antivirals, and drug delivery systems....
- This contract is a $249,999.09 Small Business Innovation Research (SBIR) Phase I award from the Department of the Army Medical Command to Zymeron Corporation, a minority-owned biotechnology company based in Research Triangle Park, North Carolina. The award supports the research and development of a "Novel Antibiotic Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections." As a prime contractor, Zymeron has experience providing medical research, engineering services, IT...
- This is a $224,999 firm fixed-price contract awarded to Zymeron Corporation, a minority-owned small business, by the Defense Advanced Research Projects Agency (DARPA) under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a lab-on-chip microfiltering and imaging device for rapid and automated sterility testing. This effort aligns with DARPA's mission to provide game-changing capabilities to the warfighter and its focus on leveraging small...
- This is a Small Business Innovative Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Healthcare Inc., a for-profit Subchapter S corporation. The $224,459 Firm Fixed Price contract is for the development of an "Automated System for Hemorrhage Control and Resuscitation at Point of Injury", which aligns with DARPA's mission to provide game-changing capabilities to warfighters. The original solicitation was a Broad Agency...